Us Congress 2025-2026 Regular Session

Us Congress House Bill HB4273

Introduced
7/2/25  
Refer
7/2/25  

Caption

Over-the-Counter Monograph Drug User Fee Amendments

Impact

The enactment of HB 4273 is expected to have significant implications for state laws governing pharmaceutical sales and distribution. By implementing a structured fee system for manufacturers and importers of OTC drugs, this bill will facilitate more rigorous oversight of these products, aiming to improve public health outcomes. Importantly, the legislation is designed to ensure that OTC drugs remain accessible while maintaining safety standards, thus balancing regulation and market accessibility for consumers.

Summary

House Bill 4273, known as the Over-the-Counter Monograph Drug User Fee Amendments, seeks to amend the Federal Food, Drug, and Cosmetic Act to enhance and extend the fee program applicable to over-the-counter (OTC) monograph drugs. Introduced on July 2, 2025, the bill aims to allow the Food and Drug Administration (FDA) to collect user fees to support the review and approval processes for OTC drugs, ensuring they meet safety and efficacy standards. This legislative effort recognizes the growing importance of OTC medications in the market and aims to provide a more sustainable funding model for their regulation.

Contention

However, the proposed changes have sparked discussions among stakeholders. Proponents argue that the fees will provide the FDA with necessary resources to effectively oversee an ever-expanding market of OTC products, which can sometimes lack comprehensive regulatory scrutiny. Critics may express concerns over the potential financial burden these fees may impose on smaller manufacturers, possibly affecting market competition. Furthermore, there may be debates regarding how effectively these funds will be allocated and monitored to ensure they directly benefit public health initiatives related to OTC drugs.

Companion Bills

No companion bills found.

Previously Filed As

US SB1844

Animal Drug and Animal Generic Drug User Fee Amendments of 2023 Animal Generic Drug User Fee Amendments of 2023 Animal Drug User Fee Amendments of 2023

US HB1418

Animal Drug and Animal Generic Drug User Fee Amendments of 2023

US HB10409

To address the high costs of health care services, prescription drugs, and health insurance coverage in the United States, and for other purposes.

US HB10370

To amend the Federal Food, Drug, and Cosmetic Act to establish certain labeling requirements for caffeine, and for other purposes.

US HB9027

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025

US HB9425

Tobacco User Fee Modernization Act of 2024

US SB5638

A bill to secure the supply of drugs in the United States, and for other purposes.

US HB10255

Countering Wrongful Detention Act of 2024

US HB10239

End Drug Shortages Act

US HB8267

Old Drugs, New Cures Act

Similar Bills

US SB2292

Over-the-Counter Monograph Drug User Fee Amendments

CA AB1933

Pupil health: sudden cardiac arrest: athletic activities.

OK SB108

The Uniform Controlled Dangerous Substances; allowing the court to order certain actions; permitting certain punishment; requiring certain persons be guilty of a felony; requiring the court to make certain orders. Effective date.

OK SB108

The Uniform Controlled Dangerous Substances; allowing the court to order certain actions; permitting certain punishment; requiring certain persons be guilty of a felony; requiring the court to make certain orders. Effective date.

OK HB1615

Public health and safety; providing separate penalties for unlawfully possessing controlled dangerous substances; effective date.

OK HB1615

Public health and safety; providing separate penalties for unlawfully possessing controlled dangerous substances; effective date.

OK HB2153

Uniform Controlled Dangerous Substance Act; prohibited acts and penalties; authorizing certain drug testing requirement; authorizing court to impose certain punishment; effective date.

OK HB2153

Uniform Controlled Dangerous Substance Act; prohibited acts and penalties; authorizing certain drug testing requirement; authorizing court to impose certain punishment; effective date.